Literature DB >> 20599692

Resistance characteristics of influenza to amino-adamantyls.

Peleg Astrahan1, Isaiah T Arkin.   

Abstract

The recent outbreaks of avian flu in Southeast Asia and swine flu in Mexico City painfully exemplify the ability of the influenza virus to rapidly mutate and develop resistance to modern medicines. This review seeks to detail the molecular mechanism by which the influenza virus has obtained resistance to amino-adamantyls, one of only two classes of drugs that combat the flu. Amino-adamantyls target the viral M2 H(+) channel and have become largely ineffective due to mutations in the transmembrane domain of the protein. Herein we describe these resistance rendering mutations and the compounded effects they have upon the protein's function and resulting virus viability. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599692     DOI: 10.1016/j.bbamem.2010.06.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.

Authors:  Rami Musharrafieh; Chunlong Ma; Jun Wang
Journal:  Antiviral Res       Date:  2018-03-06       Impact factor: 5.970

2.  Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.

Authors:  Eva Torres; Roser Fernández; Stéphanie Miquet; Mercè Font-Bardia; Evelien Vanderlinden; Lieve Naesens; Santiago Vázquez
Journal:  ACS Med Chem Lett       Date:  2012-10-22       Impact factor: 4.345

3.  Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.

Authors:  Esmeralda Alvarado-Facundo; Yamei Gao; Rosa María Ribas-Aparicio; Alicia Jiménez-Alberto; Carol D Weiss; Wei Wang
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

4.  Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.

Authors:  Rami Musharrafieh; Panagiotis Lagarias; Chunlong Ma; Raymond Hau; Alex Romano; George Lambrinidis; Antonios Kolocouris; Jun Wang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-31

5.  Emergence and evolution of avian H5N2 influenza viruses in chickens in Taiwan.

Authors:  Chang-Chun David Lee; Huachen Zhu; Pei-Yu Huang; Liuxia Peng; Yun-Cheng Chang; Chun-Hung Yip; Yao-Tsun Li; Chung-Lam Cheung; Richard Compans; Chinglai Yang; David K Smith; Tommy Tsan-Yuk Lam; Chwan-Chuen King; Yi Guan
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

Authors:  Eva Torres; María D Duque; Marta López-Querol; Martin C Taylor; Lieve Naesens; Chunlong Ma; Lawrence H Pinto; Francesc X Sureda; John M Kelly; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2011-12-02       Impact factor: 3.641

7.  A Single Amino Acid Residue R144 of SNX16 Affects Its Ability to Inhibit the Replication of Influenza A Virus.

Authors:  Wenjun Shi; Li Jiang; Miaomiao Ye; Bo Wang; Yu Chang; Zhibo Shan; Xuyuan Wang; Yuzhen Hu; Hualan Chen; Chengjun Li
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

8.  An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus.

Authors:  Mindaugas Juozapaitis; Étori Aguiar Moreira; Ignacio Mena; Sebastian Giese; David Riegger; Anne Pohlmann; Dirk Höper; Gert Zimmer; Martin Beer; Adolfo García-Sastre; Martin Schwemmle
Journal:  Nat Commun       Date:  2014-07-23       Impact factor: 14.919

9.  Effect of Forsythiaside A on the RLRs Signaling Pathway in the Lungs of Mice Infected with the Influenza A Virus FM1 Strain.

Authors:  Xiao Zheng; Yingjie Fu; Shan-Shan Shi; Sha Wu; Yuqi Yan; Liuyue Xu; Yiwei Wang; Zhenyou Jiang
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

10.  Zika M-A Potential Viroporin: Mutational Study and Drug Repurposing.

Authors:  Prabhat Pratap Singh Tomar; Miriam Krugliak; Anamika Singh; Isaiah T Arkin
Journal:  Biomedicines       Date:  2022-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.